MEDICOX Co., Ltd. (KOSDAQ:054180)
South Korea · Delayed Price · Currency is KRW 2,295.00
-270.00 (-10.53%)
At close: Jul 2, 2025
MEDICOX Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -11,895 | -21,435 | -34,427 | -42,619 | -23,935 |
Depreciation & Amortization | 1,729 | 2,103 | 2,971 | 3,272 | 2,209 |
Loss (Gain) From Sale of Assets | 1,383 | 3,657 | -842.26 | -457.79 | -2,492 |
Asset Writedown & Restructuring Costs | - | 2,824 | 179.25 | 4,302 | - |
Loss (Gain) From Sale of Investments | 1,030 | 488.03 | 11,709 | 266.11 | 2,510 |
Loss (Gain) on Equity Investments | 2,796 | 2,374 | 1,284 | 9,058 | 9,240 |
Provision & Write-off of Bad Debts | -280 | -454.73 | 264.78 | 171.54 | -0.04 |
Other Operating Activities | 722.54 | 2,032 | 10,664 | 17,409 | 4,952 |
Change in Accounts Receivable | 26.13 | -859.06 | -674.73 | -1,194 | 163.61 |
Change in Inventory | -124.49 | 527.34 | -412.09 | -546.31 | -48.75 |
Change in Accounts Payable | 618.71 | 553.38 | 845.39 | -172.98 | 361.12 |
Change in Unearned Revenue | - | - | -7.68 | -1.28 | - |
Change in Other Net Operating Assets | 561.74 | 1,557 | -411.35 | 1,321 | -204.08 |
Operating Cash Flow | -3,432 | -6,633 | -8,892 | -9,156 | -7,244 |
Capital Expenditures | -774.02 | -366.46 | -447.75 | -3,700 | -1,563 |
Sale of Property, Plant & Equipment | 8,028 | 63.98 | 181.82 | 257.27 | 54.34 |
Cash Acquisitions | - | - | - | -2,811 | - |
Divestitures | - | - | 1,649 | - | - |
Sale (Purchase) of Intangibles | - | -0.39 | -48.7 | -2,768 | - |
Investment in Securities | 3,136 | 3,372 | -13,776 | 782.85 | -20,749 |
Other Investing Activities | -4,793 | -936 | 2,796 | -3,435 | -933.61 |
Investing Cash Flow | 5,987 | 1,469 | -10,340 | -15,502 | -23,959 |
Short-Term Debt Issued | 2,072 | 19,926 | 11,502 | 20,374 | 3,500 |
Long-Term Debt Issued | - | 4,060 | 4,038 | 39,586 | 22,170 |
Total Debt Issued | 2,072 | 23,986 | 15,540 | 59,959 | 25,670 |
Short-Term Debt Repaid | -8,576 | -7,894 | -8,439 | -23,455 | -7,000 |
Long-Term Debt Repaid | -3,855 | -12,503 | -1,993 | -13,641 | -21,140 |
Total Debt Repaid | -12,431 | -20,397 | -10,432 | -37,095 | -28,140 |
Net Debt Issued (Repaid) | -10,358 | 3,589 | 5,108 | 22,864 | -2,470 |
Issuance of Common Stock | 6,959 | 993.56 | 12,955 | - | 34,090 |
Repurchase of Common Stock | -6.13 | - | - | -38.84 | - |
Other Financing Activities | -1.46 | - | -0 | 621.22 | 633.17 |
Financing Cash Flow | -3,406 | 4,583 | 18,063 | 23,446 | 32,253 |
Miscellaneous Cash Flow Adjustments | 0 | 0 | - | 0 | -0 |
Net Cash Flow | -851.86 | -581.51 | -1,169 | -1,212 | 1,051 |
Free Cash Flow | -4,206 | -7,000 | -9,340 | -12,855 | -8,807 |
Free Cash Flow Margin | -14.94% | -22.87% | -34.75% | -63.34% | -50.47% |
Free Cash Flow Per Share | -781.15 | -1824.53 | -4836.04 | -9129.83 | -9980.78 |
Cash Interest Paid | 1,070 | 1,453 | 424.34 | 1,019 | 871.64 |
Cash Income Tax Paid | -72.83 | 127.18 | 14.25 | 60.69 | 4.73 |
Levered Free Cash Flow | 290.54 | -10,313 | -15,363 | -10,629 | 983.45 |
Unlevered Free Cash Flow | 1,198 | -8,870 | -12,895 | -8,954 | 3,225 |
Change in Working Capital | 1,082 | 1,778 | -660.45 | -593.73 | 271.89 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.